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Abstract
Background: Macrofungi have an established history of use in traditional oriental medicine. Anthracophyllum lateritium
is a terrestrial macrofungus found in the dry zone forest reserves in Sri Lanka. Yet there are no scientific reports on
bioactive properties of this species. Hence, the current study was aimed at determining the antioxidant potential, in
vitro antiproliferative activity and apoptotic effect induced by crude methanolic extract of A. lateritium against
RD sarcoma cell line.
Method: The crude extract of A. lateritium was dissolved in methanol (MEFCA) and antioxidant activity was evaluated
using in vitro assays: inhibition of DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging, ferric ion reducing power
and 2-deoxy-D-ribose degradation assay. Total phenol and flavonoid contents of MEFCA were assayed using folin
Ciocalteu method and aluminium chloride colorimetric method. In vitro cytotoxicity was determined using MTT assay
against RD cells after 24 h exposure to MEFCA. Ethidium bromide/ acridine orange staining, DNA fragmentation and
protein synthesis experiments were used to study the apoptotic features and antiproliferative activities of the treated
cells. Glutathione assay and griess nitrite assay were used to analyze the reduced glutathione content and liberation of
nitric oxide from apoptotic cells.
Results: MEFCA showed promising antioxidant activity with EC50 values of 8.00 ± 0.35 μg/mL for DPPH scavenging and
83.33 ± 0.45 μg/mL for 2-deoxy-D-ribose degradation assay. The phenolic content was 265.15 ± 0.46 of (w/w) % of
Gallic acid equivalents and flavonoid content was 173.01 ± 0.35 of (w/w) % of Epigallocatechingallate. A. lateritium
showed strong in vitro cytotoxic activity with an EC50 of 18.80 ± 4.83 μg/mL for MTT assay against RD cells. Ethidium
bromide/acridine orange staining and DNA fragmentation indicated the apoptotic features of treated cells.
Protein levels showed a dose dependent decrease supporting the fact that A. lateritium induces apoptosis of treated
cells. Glutathione content and nitric oxide content of cells exhibited a dose dependent increase suggesting the
apoptosis of RD cells was mediated by both nitrie ions and nitric oxide.
Conclusions: The crude extract of the A. lateritium exhibited potent antioxidant, antiproliferative activity and apoptotic
effect against RD cells providing supportive evidence for the ethnopharmacological use of this fungus in control of
oxidative damage and remedy of cancer.
Keywords: Macrofungi, Traditional medicine, Anthracophyllum lateritium, Antioxidant activity, Cytotoxicity, Apoptosis
* Correspondence: diluarchive@gmail.com
1Department of Plant Sciences, Faculty of Science, University of Colombo,
Colombo 03, Sri Lanka
2Department of Molecular Biology and Biochemistry, Faculty of Medicine,
University of Colombo, Colombo 03, Sri Lanka
Full list of author information is available at the end of the article
© 2015 Fernando et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fernando et al. BMC Complementary and Alternative Medicine  (2015) 15:398 
DOI 10.1186/s12906-015-0924-9
Background
Attributing to deep and firm roots in uses of macro fungi
in the traditional medical practice of the far Eastern and
recently in western world, constituent molecules of macro
fungi organelles and secondary metabolites have long been
believed to have important pharmacological properties
such as antioxidant, antimicrobial, anticancer, cholesterol
lowering and immunostimulatory effects [1, 2]. The active
metabolites of the medicinal mushrooms such as
Ganoderma lucidum, Ramaria flava, Russula delica,
Thelephora ganbajan are found to have health promoting
properties including antioxidant and antitumor activity
[3]. Numerous publications indicate that the most import-
ant hazard for human diseases is posed by uncontrolled
production of reactive oxygen species (ROS), including
free radicals [4]. All living cells, including human cells, are
continuously exposed to a variety of stress conditions
leading to generate reactive oxygen species. From all free
radical species, ˙OH and ˙O2- radicals are mainly involved
in the oxidative damage, induces in the biological systems
[5]. Natural antioxidants in the body act as a major
defense against radical mediated toxicity by protecting the
damage caused by free radicals [6, 7]. However, the en-
dogenous mechanisms involved in free radical scavenging
in the living cell sometimes become unbalanced and may
be inadequate to neutralize the free radicals generated ex-
cessively. Hence, abundance of free radicals leads to be
the major cause for deleterious conditions such as cancer
and other degenerative diseases including cardiovascular
diseases and hypercholesterolemia [8–10]. In spite of the
availability of novel antineoplastic agents, cancer remains
as the second leading cause of death affecting millions of
people per year. The recent cancer therapies such as
radiotherapy, chemotherapy and hormonal therapy
has been made a modest progress in reducing the
morbidity and mortality caused by cancer to the ex-
pected level [11, 12]. On contrary, molecules derived
from natural sources including fungi and plants con-
tinue to play a dominant role in the discovery and
development of novel and effective drug leads for
cancer with minimal side effects. Currently, the medi-
cinal importance of the wild mushrooms are being
studied widely for their capacity to protect living cells
and organisms from cancer [13, 14]. Being a tropical
country, Sri Lankan biota has enormous fungal diver-
sity and consists of a variety of macrofungi species
with medicinal and aromatic values. Although, some
of the species are used in traditional medicine, most
of them are still not explored scientifically for their
medicinal values [15]. Anthracophyllum lateritium is a
terrestrial basidiomycete which is rarely found in the
dry zone forest reserves of Sri Lanka. It belongs to
the family of marasmiaceae. A. lateritium is a small
shelf like fungus grown in large numbers. There is no
stalk and caps are smooth with dull brown color [16]. Al-
though, there are no reported studies on biological activ-
ities of A. lateritium, Lentinus edodes which belongs to
the same family (marasmiaceae) has shown important bio-
active properties including antioxidant and antiprolifera-
tive activity [16]. Hence, the current study is an extended
effort to broaden and uncover the antioxidant and cyto-
toxic properties of A. lateritium which leads to develop-
ment of drug leads in the treatment of cancer and other
degenerative diseases. The fruiting bodies of the macro-
fungus were used to determine the biological activities.
Methods
Chemicals and equipments
Folin ciocalteu reagent, sodium carbonate (Na2CO3),
aluminium chloride (AlCl3), sodium nitrite (NaNO2), so-
dium hydroxide (NaOH) and chemicals needed for cell
culture and cytotoxicity studies were purchased from
Sigma–Aldrich (P.O. box 14 508, St Louis, MO 63178
USA). 1-Diphenyl-2-picrylhydrazyl (DPPH), Triton X-
100 solution (1 %), gallic acid, sulfanilamide and
ortho-phosphoric acid, (−)-Epigallocatechinegallate were
purchased from Fluka (Fluka chemie GmbH, CH – 9471
Buchs). Ascorbic acid, methanol and Dichloromethane
were purchased from BDH Chemicals (Poole, England).
Tris base was purchased from Promega (Promega Corpor-
ation, Madison, WI 53711–5399, USA). All chemicals
used were of analytical grade.
Shimadzu UV 1601 UV visible spectrophotometer
(Shimadzu Corporation, Kyoto, Japan) was used to
measure the absorbance. Rotatory evaporator (BUCHI
Rota vapor R-200) was used to obtain the crude extract
of A. lateritium. Cells were incubated at 37 °C in a
humidified CO2 incubator (SHEL LAB/Sheldon manufac-
turing Inc. Cornelius, OR 97113, USA). Olympus (1X70-
S1F2) inverted fluorescence microscope (Olympus Optical
Co. Ltd. Japan) for observation of cells and photographs
were taken using a Nikon D700 camera (Nikon D700,
Japan). Deionized water from LABCONCO (waterpro-
plus) UV ultra-filtered water system (LABCONCO
Corporation, Kansas city, Missouri 64132–2696) or
distilled water was used in all experiments.
Fungal material
The specimen of A. lateritium was collected from the
dry zone forest reserves of Dambulla in Sri Lanka during
the period of September 2012 to October 2013. They
were collected into paper bags and packed loosely with
proper ventilation during the transportation. The
identity of the specimen was achieved by the Depart-
ment of Plant Science, Faculty of Science, University
of Colombo (Genbank Accession No.: KP757737).
Voucher specimens were deposited at the same insti-
tute (UOC:DAMIA:D26).
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Preparation of the extract
Mature fruiting bodies of A. lateritium were brush
cleaned, dried in the oven at 40 °C to a constant mass
and pulverized. The dried powder of each specimen
(10 g) was sonicated sequentially with 150 mL of 100 %
methanol, 99 % dichloromethane and methanol: dichlo-
romethane (1:1) mixture at 30 °C for 1 h. Each extract
was filtered twice through Whatman No. 1 filter paper.
The filtrates were pooled together and evaporated to
dryness at 40 °C under reduced pressure using rotatory
evaporator to obtain the crude extract. Crude extract
was dissolved in methanol and used for further experi-
ments (MEFCA).
Determination of antioxidant activity
Antioxidant activity by 1, 1- diphenyl-2-picrylhydrazyl
(DPPH) radical, ferric ion reducing power and nonsite-
specific hydroxyl radical mediated 2- deoxy-D-ribose
degradation of the MEFCA were determined according
to the methods described previously with modifications
[17]. The percentage antioxidant capacity (% AI) was
calculated from the following equation: % AI = [(absorb-
ance of control-absorbance of sample)/absorbance of
control] x 100 %. The effective concentration of the
sample required to scavenge the respective radical by
50 % (EC50) was calculated using the linear segment of
the curve obtained with % AI against concentration.
Total phenol content (TPC) and total flavonoid
content (TFC)
TPC and TFC of the MEFCA were determined by the
Folin - Ciocalteau method [18, 19] and slightly modified
method of aluminium chloride colorimetric assay [20].
Cell lines and cell culture
The human muscle rhabdomyosarcoma (RD) cell line
was used to assess the cytotoxicity of the MEFCA. The
RD cell line is derived from a biopsy of 7 year old child
having pelvic refractory RMS, previously treated with
cyclophosphamide and radiation (McAlliste et al., 1969).
RD cell line was obtained from the Medical Research In-
stitute, Colombo 08, Sri Lanka. The cells were cultured
in DMEM supplemented with 10 % heat inactivated fetal
bovine serum (FBS), HEPES, 3 % glutamine, sodium bi-
carbonate and antibiotic (penicillin/streptomycin) and
incubated at 37 °C in a humidified CO2 incubator.
MTT assay
Cytotoxic activity was determined using MTT cell viabil-
ity assay after 24 h treatment of the MEFCA to RD cells.
Metabolically active cells reduce MTT (3, 4, 5-(di-
methyl-thiazol-2-yl) 2-5-diphenyl tetrazolium bromide)
in to purple colored formazan crystals. RD cells (2 × 10 5
cells/well) were seeded in 24-well plates and incubated
overnight with 1 mL of the medium described above.
The resulting monolayer of cells (70 % confluence)
was treated with different concentrations of the
MEFCA (1–150 μg/mL) and incubated for 24 h at
37 °C. In all experiments, cycloheximide (5 mM,
50 μL) was used as the positive control and negative
control contained only the growth media. The culture
medium was replaced with fresh medium (1 mL) and
MTT (5 mg/ml; 100 μL) was added to each well. The
cells were incubated at 37 °C for 3 h and the medium
was aspirated carefully. The remaining formazan crys-
tals were solubilized with 750 μL of 0.05 M HCl (in
2-propanol) and absorbance was measured at 570 nm.
Percentage cell viability = [(Absorbance of untreated cells
-Absorbance of treated cells)/Absorbance of untreated
cells]*100. The net absorbance from the wells of the un-
treated cells (negative control) was taken as the 100 % via-
bility. EC50 was determined by regression analysis of the
corresponding dose response curve.
Morphological determination
The morphological changes of RD cells after the treat-
ment with different concentrations of the MEFCA over
24 h were detected by microscopic examination of cells.
Morphological changes were compared with negative
and positive controls under fluorescence microscope.
Ethidium bromide/Acridine orange staining
Ethidium bromide and acridine orange staining was per-
formed to investigate the apoptosis induced by MEFCA
against RD cells. Ethidium bromide (EB) is only occu-
pied by cells with damaged cell membranes. Acridine or-
ange (AO) permeates via both live and dead cells, while
stains the DNA making nucleus appear in green. Thus,
live cells will be uniformly stained green. Apoptotic cells
will be stained in orange or red with acriding orange de-
pending on the degree of loss of membrane integrity and
co-staining with ethidium bromide. Cells were seeded in
chamber slides and the confluent layer was treated with
the MEFCA at different concentrations for 24 h at 37 °C
as described previously. The adherent cells were washed
with 200 μL of PBS and 2 μL of the dye mixture contain-
ing ethidium bromide (100 mg/mL) and acridine orange
(100 mg/mL) was placed on each well of the chamber
slide. Chamber slides were examined immediately under
the florescence microscope. Images were photographed
using a Nikon D 700 camera connected to microscope.
DNA fragmentation assay
RD cells were seeded in culture flasks (25 mL) and the
confluent layer was treated with the MEFCA at different
concentrations for 24 h at 37 °C as described previously.
The DNA fragmentation assay was carried out according
to a previously described method [21].
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Estimation of protein content
RD cells were seeded in 24 well plates and the confluent
layer was treated with the MEFCA at different concen-
trations (2–60 μg/mL) for 24 h at 37 °C as described pre-
viously. The cell lysates were obtained by dissolving the
treated monolayers of cells in 1 mL of 0.1 % Triton-X
solution. The protein content in the cell lysate was
determined using a method described previously [22].
Griess nitrite assay
The nitric oxide content of the supernatant obtained
from RD cells seeded in 24 well plates treated with
MEFCA was estimated using the griess nitrite assay [23].
The nitrite content was calculated based on a NaNO2
standard curve.
Determination of reduced glutathione
The reduced glutathione (GSH) content of the RD cell
lysates was determined using the methods described pre-
viously with slight modifications [24, 25]. A series of
reduced glutathione standards (0.5 – 3 μg/mL) treated
in a similar manner were also performed to determine
the reduced glutathione content in cell lysate.
Calculations and statistics
All experiments were performed in triplicate and values
shown are representative for at least three independent
experiments. All the results of the experiments were
expressed as the mean ± standard deviation (Mean ± SD).
Least square linear regression analysis was applied using
Microsoft excel and linear segment of the curve of per-
centage inhibition plotted with concentration was used
to determine the EC50 values. R
2 > 0.99 was considered
as linear for the calibration curves.
Result
Antioxidant activity
The EC50 value which is the effective concentration of
the MEFCA required to scavenge DPPH radicals by
50 % was 8.00 ± 0.35 μg/mL (Fig. 1). L- Ascorbic acid
was used as the standard antioxidant to compare the
EC50 value obtained for MEFCA. Interestingly, EC50 cal-
culated for MEFCA was closer to the EC50 value ob-
tained for ascorbic acid (5.50 ± 0.45 μg/mL) implying its
strong radical scavenging activity. In Ferric ion reducing
power assay, MEFCA showed strong reducing power
forming blue or green coloured complex with reduction
of Fe3+/ferricyanide complex in to the ferrous form de-
pending on the reducing power of each concentration of
the extract. Ferric ion reducing power was gradually
increased in a dose dependent manner in the range of
20–400 μg/mL (Fig. 2). The effective concentration of
the MEFCA required to scavenge the reactive hydroxyl
radicals by 50 % (EC50) evaluated by hydroxyl radical
mediated 2- deoxy-D-ribose degradation was 83.33 ±
0.45 μg/mL (Fig. 3). The value was higher than the
standard antioxidant, gallic acid (10.04 ± 0.27 μg/mL).
Phenolic and flavonoid content
The phenolic content of the MEFCA was 265.15 ± 0.46
of Gallic acid equivalents (GAE)/dry weight (mg) of
sample and flavonoid content was 173.01 ± 0.35 of Epi-
gallocatechingallate (EGCG)/dry weight (mg) of sample.
Cytotoxicity and apoptosis assays
MTT assay
A dose response curve of percentage cell viability against
the concentration of the extract was obtained using
Fig. 1 Dose response curves for DPPH radical scavenging capacity of
MEFCA. The % antioxidant index was plotted against concentration of
the sample. The graphical data are represented as mean ± SD of three
independent experiments
Fig. 2 Ferric ion reducing power assay for MEFCA. The absorbance
(A700) was plotted against concentration of the sample. The
graphical data are represented as mean ± SD of three
independent experiments
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result obtained for MTT cell viability assay (Fig. 4). The
EC50 value obtained for the mean of the three independ-
ent sample preparations against RD cells was 18.80 ±
4.83 μg/mL. Positive control (cycloheximide) exhibited
78.45 ± 2.22 % growth inhibition at the concentration
(5 mM, 50 μL) used.
Morphological changes
The morphological changes observed on RD cells after
treatment of MEFCA are represented in Fig. 2. The cell
morphology of untreated cells appeared in elongated
shape and treated cells appeared with cellular shrinkage,
oval or irregular in shape and condensed cytoplasm. The
cells treated with highest concentration of the MEFCA
(100 μg/mL) displayed the detached and round shape
dead cells as indicated in Fig. 5.
Ethidium bromide/acridine orange staining
Morphological changes of cells stained with ethidium
bromide/acridine orange (1:1) after treatment of extract
indicated that untreated cells (negative control) appeared
with the normal nuclei presented bright green. Early
apoptotic cells showed greenish yellow nuclei and late
apoptotic cells indicated condensed orange red nuclei.
Dead cells appeared in red. Chromatin condensation,
nuclear fragmentation, presence of apoptotic bodies and
blebbing formation of apoptotic cells were also evident
upon examination of stained cells with ethidium brom-
ide/acridine orange (Fig. 6).
DNA fragmentation
DNA fragmentation was observed at a concentration of 10,
20, 50, 100 μg/mL of MEFCA after 24 h exposure (Fig. 7).
A unique ladder pattern and DNA shearing related to
apoptosis was observed by DNA extracted from treated
cells with fungal extract. The higher dose (100 μg/mL) of
the extract induced significantly greater fragmentation or
shearing of the DNA compared to lower concentrations.
Estimation of protein content
The protein levels of the cell lysates of treated RD cells
exhibited a dose dependent decrease as shown in Fig. 8.
Griess nitrite assay
Nitric oxide (NO) content in the cell supernatant ana-
lyzed by griess nitrite assay showed a dose dependent in-
crease compared to the negative control (Fig. 9).
Determination of reduced glutathione
The reduced glutathione (GSH) content in the RD cell
lysate showed a dose dependent increase compared to
the negative control (Fig. 10).
Discussion
Among the secondary metabolites produced by macro-
fungi, bioactive phenols and flavonoid derivatives are of
predominant due to their strong capacity for free radical
scavenging. Mainly, polyphenols have gained major im-
portance in scavenging free radicals which is correlated
to their chemical structure consisting of an aromatic
ring with hydroxyl substituents [26]. This effect is dir-
ectly involved with subsidizing anticancer activity against
human cancer cells. Therefore, there is a recent upsurge
in the interest of mushrooms, due to their high content
of polyphenol, which positively correlates with the anti-
oxidant activity and antiproliferative effect [27–29].
Fig. 3 Hydroxyl radical mediated 2-deoxy-D-ribose degradation
assay for MEFCA. The % inhibition was plotted against concentration
of the sample. The graphical data are represented as mean ± SD of
three independent experiments
Fig. 4 The percentage induction of cytotoxicity (inhibition of cell
proliferation) against RD cell line as determined by MTT assay, after
24 h treatment with the MEFCA. The graphical data are represented
as mean ± SD of three independent experiments
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In the current study, MEFCA showed promising anti-
oxidant activity with DPPH, Ferric ion reducing power,
and OH radical scavenging capacities. DPPH scavenging
capacity was found to be highest, followed by hydroxyl
radical scavenging activity. Also it exhibited in vitro
cytotoxicity and large quantities of phenol and flavonoid
compounds. These findings suggest high polyphenol
content of fungi largely contribute for strong antioxidant
and antiproliferative activity. Compelling cytotoxic activ-
ity against RD cell line was found using MTT cell viabil-
ity assay which is a well-established method to assess the
cell viability. As evident in Fig. 1, dose dependent in-
crease was observed for in vitro cytotoxicity for RD cell
line over a range of 2–80 μg/mL of MEFCA. Interest-
ingly, a maximum of 95 % inhibition of cell growth was
observed at concentrations over 80 μg/mL. Antiprolifer-
ative activity of MEFCA was found to be approximately
eight times greater than the activity shown by
Ganoderma lucidum which is an important medicinal
mushroom used today, acclaimed as “mushroom of
immortality”. G. lucidum possesses an anticancer effect
with an EC50 of 125.00 ± 0.03 μg/mL as evaluated by
MTT assay [30, 31]. In addition, methanol extract of
G. lucidum exhibited antioxidant activity on the 1,1-
diphenyl-2-picrylhydrazyl radical with an EC50 value
of 1.162 ± 0.016 mg/mL [32]. This is found to be
seventy times lower than DPPH antioxidant activity
shown by MEFCA. Pleurotus cystidiosus is another
important edible mushroom which possesses antipro-
liferative activity. It has been shown cytotoxic properties
against Hep-2 cells with an EC50 value of 3.6 mg/mL for a
fraction of methanol:water (7:3) [33]. MEFCA also exhibits
strong antiproliferative activity compared to the activity
shown by P. cystidiosus.
Distinct morphological changes observed on tumor
cells after treatment of extract of A. lateritium, com-
pared to negative control reveal its antitumor activity.
Microscopic examination of cell morphology of treated
cells following 24 h incubation exhibited characteristic
features of dead cells which were then further analyzed
by ethidium bromide/acridine orange staining method.
Cells stained with AO/EB in yellowish green indicate the
signs of early apoptosis and orange red represents late
apoptotic cells. Chromatin condensation and nuclear
fragmentation were predominantly observed apoptotic
features for treated cells with high concentrations of the
extract and quantity of apoptotic cells was gradually
increased with the treatment dose. Morphological
characterization of treated cells revealed that the mode
of action of cell death induced by the methanol extract
of A. lateritium was mediated through apoptosis. It
strengthens the results obtained by MTT assay.
Fig. 5 Fluorescent micrographs of RD cell line after 24 h of incubation with the MEFCA at different concentrations. a-negative Control; b-Positive
Control (Cycloheximide); c- 20 μg/mL; d- 100 μg/mL. Live cells have characteristic polygonal shape and dead cell are rounded. Reduction in cell
density was also observed in positive control and the treated cells with highest concentration (Original magnification 20×)
Fig. 6 Apoptotic morphology detection by Acridine orange-ethidium bromide (AO/EB) fluorescent staining of RD cell line treated with the
MEFCA. a-negative control; b- cycloheximide as the positive control (5 mM; 50 μL); c- 20 μg/mL, d- 50 μg/mL of the extract. Green arrows: live
cells, greenish yellow: early apoptotic cells, orange red: late apoptotic cells, red: dead cells (some cells are fragmented and become faded). This
figure denotes the results of at least 3 independent experiments (Original magnification 40×)
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This was further confirmed by the DNA fragmentation
assay indicating a unique ladder banding pattern (Fig. 4).
Cleavage of oligonucleosomal DNA at the internucleoso-
mal linker sites yielding DNA fragments in multiples of
180 bp is reflected as the biochemical hallmark of apop-
tosis [34, 35]. Appearance of such fragments resulting in
a ladder formation was evident when fragmented DNA
was isolated from apoptotic cells treated with the
respective drug/extract or decoction and subjected to
agarose gel electrophoresis.
Fig. 7 Induction of apoptosis by DNA fragmentation shown by
Agarose gel electrophoresis. Lane 1: DNA molecular weight marker,
Lane 2: 10 μg/mL, Lane 3: 20 μg/mL of extract, lane 4: 50 μg/mL of
extract, Lane 5: 100 μg/mL
Fig. 8 Protein content in the RD cell lysate after 24 h treatment with
the MEFCA. The graphical data are represented as mean ± SD of
three independent experiments
Fig. 9 Nitrite content in the RD cell supernatant after 24 h treatment
with the MEFCA. The graphical data are represented as mean ± SD of
three independent experiments
Fig. 10 The reduced glutathione (GSH) content in the RD cell lysate
after 24 h treatment with the MEFCA. The graphical data are
represented as mean ± SD of three independent experiments
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Protein stability is a key regulatory mechanism in the
control of cell growth, cell cycle and apoptosis. The se-
lective degradation or stabilization of intracellular pro-
teins by ubiquitin-dependent pathways is essential for
the regulation of many cellular processes. During apop-
tosis, regulatory and other proteins have been identified
as target substrates for ubiquitination [36]. Apoptosis is
massively occurred in treated cells with high doses of
MEFCA. Hence, protein levels are also gradually de-
creased with the treatment dose of the extract. The re-
sult reveals that protein levels of the treated cells
exhibited a dose dependent decrease.
Nitrite content in the cell supernatant investigated by
the griess nitrite assay showed a dose dependent in-
crease implying the role of NO in tumor regression. The
role of NO in mediating tumor regression has been re-
ported in a number of studies [37–39]. Higher NO levels
are known to suppress metastasis via alterations of the
expression of apoptosis associated proteins. Nitric oxide
(NO) is synthesized endogenously by a family of NO
synthases and has been demonstrated to involve in a var-
iety of biological signaling processes, including apoptosis.
As NO is a highly reactive free radical within biological
systems, it can react with other free radicals, molecular
oxygen and heavy metals. NO can react rapidly in the
intracellular environment to form nitrites, which in turn
analyzed by griess nitrie assay. It has been reported that
the biological effects of NO can be also mediated by the
products of different NO metabolites. These metabolites
including nitrites are known to play a vital role in mediat-
ing genotoxic effects via DNA damage caused by DNA
modification or DNA strand breakage. This NO metabo-
lites mediated DNA damage induces cellular apoptosis
[40–42]. Therefore, it is evident that generated nitrite ions
from NO played a significant role in regression of RD cell
growth. These findings suggest the apoptosis of RD cells
was mediated by both nitrie ions and nitric oxide.
NO increases TCA cycle flux via increase in glucose
uptake and increase in cellular glutamine. This potential
link between the increase in TCA cycle activity and NO
in cancer cells may result in the production of glutathi-
one (GSH) in tumor cells [43]. In this study, the reduced
glutathione (GSH) content in the cell lysate showed a
dose dependent increase against RD cell line supporting
the positive correlation between nitric oxide content and
production of glutathione in tumor cells. It augments
the result obtained from griess nitrite assay.
Importantly, the crude organic extract of A. lateritium
possesses potent anticancer and antioxidant effect re-
vealing its pharmacological importance. To the best of
our knowledge, this is the first report on antioxidant ac-
tivity and in vitro cytotoxicity of A. lateritium. This
appears to be a potential source of novel anticancer and
antioxidant compounds.
Conclusions
The methanol extract of A. lateritium demonstrated high
antioxidant potential to variable levels as analyzed by dif-
ferent antioxidant assays. It suggests that A. lateritium is a
potential therapeutic agent for the control of oxidative
damage caused by free radicals. The potent anticancer and
apoptotic effect induced by crude extract of A. lateritium
observed in the present study imply the ethnopharmaco-
logical potential of this fungus in remedy of cancer. It can
be emerged as an important source of antioxidant and an-
titumor compounds. Further, present findings suggest
there might be a direct involvement of phenolic and fla-
vonoid compounds to the observed promising anticancer
and antioxidant effect of A. lateritium.This study pro-
vides a scientific proof of the traditional awareness in
using medicinal mushrooms as an anticancer agent.
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